Nafazatrom
Product Specifications
CAS Number
59040-30-1
Target
Lipoxygenase, Others
Related Pathways
Others, Metabolism
Bioactivity
Nafazatrom is a pyrazolinone derivative and lipoxygenase inhibitor that increases endogenous prostacyclin (PGI2) and has experimental anticancer activity. Nafazatrom is also an antithrombotic drug that increases prostacyclin levels and reduces the incidence of arrhythmias associated with cardiac injury.
Smiles
O(CCN1N=C(C)CC1=O)C2=CC3=C(C=C2)C=CC=C3
Molecular Formula
C16H16N2O2
Molecular Weight
268.31
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15092021 1 Vial
Lentiviral human MLLT3 shRNA (UAS) - Lentiviral human MLLT3 shRNA (UAS) (25)
Sign In for Pricing
View Details 
LC407804 20 µg
ZFP38 (ZSCAN21) (NM_145914) Human Over-expression Lysate
Sign In for Pricing
View Details